工程化牛奶细胞外囊泡靶向成骨细胞促进根尖周炎骨修复
本研究探讨了经成骨细胞靶向肽DPS修饰的牛奶来源细胞外囊泡(DPS-MEVs)对慢性根尖周炎(CAP)的治疗潜力。在体内外实验中,DPS-MEVs通过KLF4介导的Ndufa4上调激活氧化磷酸化,增强成骨能力并提高成骨细胞靶向性;在犬CAP模型中经根尖显微手术移植后,DPS-MEVs通过促进M2巨噬细胞极化增强骨修复并减轻炎症。
要点
- DPS-MEVs通过KLF4/Ndufa4轴激活氧化磷酸化增强成骨。
- DPS-MEVs比未修饰MEVs具有更强的成骨细胞靶向性。
- 犬CAP模型中DPS-MEVs促进M2极化、骨修复并减轻炎症。
核心结论
- 工程化DPS-MEVs通过免疫调节与组织修复双重功能,为CAP的精准治疗提供潜在策略。
研究设计与样本
- 研究采用体内外实验,并在犬CAP模型中通过根尖显微手术移植DPS-MEVs。
主要发现
- DPS-MEVs增强成骨能力并提高成骨细胞靶向性,机制涉及KLF4介导的Ndufa4上调和氧化磷酸化激活。
- 在犬CAP模型中,DPS-MEVs增强骨修复并减轻炎症,与促进M2巨噬细胞极化相关。
临床怎么用
- DPS-MEVs可能作为CAP的靶向治疗手段,兼具免疫调节和促进骨修复的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic apical periodontitis (CAP), an inflammatory disease of periapical tissues, leads to alveolar bone destruction. Current therapies lack osteoblast-targeting specificity and fail to effectively promote bone repair. Extracellular vesicles (EVs), particularly milk-derived EVs (MEVs), show potential for bone regeneration and have anti-inflammatory effects. We investigated the therapeutic potential of engineered MEVs modified with the osteoblast-targeting peptide DSPE-PEG-Mal-Cys-SDSSD (DPS) in CAP. DPS-MEVs enhanced osteogenic capacity and exhibited greater osteoblast targeting compared with unmodified MEVs through oxidative phosphorylation (OXPHOS) activation, driven by Kruppel-like factor 4 (KLF4)-mediated upregulation of NADH dehydrogenase 1 alpha subcomplex 4 (Ndufa4) in vivo and in vitro. We also transplanted DPS-MEVs into a CAP model of dogs through apical microsurgery and found that DPS-MEVs enhanced bone repair and reduced inflammation by promoting polarization of M2 macrophages. These findings highlighted the potential of engineered DPS-MEVs as a dual-functional therapy for CAP, combining immunomodulation and tissue repair to advance precision treatment for inflammatory bone diseases.
引用
- Wu SX, Song QY, Bai H, et al. Milk EVs Promote Apical Periodontitis Bone Repair via Osteoblast Targeting. J Dent Res. 2025. PMID: 41108157. doi:10.1177/00220345251368767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。